Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>HANXBIO-B IPO Begins w/ Entry Fee HKD3,232.27, Attracting 7 Cornerstone Investors
Recommend 6 Positive 9 Negative 4 |
||||
|
||||
|
HANXBIO-B (03378.HK), a biotechnology company with proprietary expertise and experience in structural biology, translational medicine, and clinical development, began its IPO today (15th). The company offers a total of 18.321 million shares, including 1.8321 million shares for the Hong Kong public offering. The offer price ranges from HKD28 to HKD32 per share, and the entry fee for a board lot of 100 shares will be HKD3,232.27, aiming to raise up to around HKD590 million. The IPO period will end on December 18, and the listing is expected to happen on December 23. The IPO has attracted seven cornerstone investors, including Fund Resources, Sage Partners Master Fund, Main Source Capital Limited, and YStem Capital, with a total investment amount of HKD93.37 million. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
